18983288589(微信同号)
18983288589(微信同号)
18908392210(微信同号)
18980413049
ChiCTR2300075841
正在进行
/
/
/
2023-09-18
/
/
Atrial fibrillation
Relationship between renal function and pharmacogenetics on plasma level of direct oral anticoagulants (DOACs)
The impact of renal function and pharmacogenetics on plasma level of direct oral anticoagulants (DOACs) in Chinese patients with renal impairment
1. Establish the range of peak and trough of DOACs level in Chinese patients 2. Delineate the relationship between plasma DOACs level and renal function in Chinese patients 3. To determine the relationship of plasma direct Xa-inhibitors level and anti-Xa activity (by using LMWH as calibrator) 4. Establish the relationship between bleeding complications and recurrent ischaemic/thromboembolic events and plasma DOACs level 5. Establish the relationship between pharmacogenetic variants and plasma DOACs level as well as the rate of bleeding complications and recurrent ischaemic/thromboembolic events
横断面
其它
Not applicable as it is not a randomized controlled trial
/
Department support from Department of Pathology, University of Hong Kong
/
400
/
2022-01-24
2025-12-31
/
1. Age >= 18 years old 2. Receiving any DOACs (dabigatran, rivaroxaban, apixaban and edoxaban) for atrial fibrillation 3. Follow up in out-patient clinic in Queen Mary Hospital;
登录查看1. Age <18 years old 2. Patients who are followed up irregularly in out-patient clinic in Queen Mary Hospital 3. Clinical information is incomplete 4. Non-Chinese;
登录查看Department of Pathology, University of Hong Kong
/
昌郁医药2024-11-22
上海和誉生物医药科技有限公司2024-11-22
云顶新耀2024-11-22
金斯瑞生物2024-11-22
细胞与基因治疗领域2024-11-22
肝脏时间2024-11-22
医药笔记2024-11-22
生物安全情报网2024-11-22
医药速览2024-11-22
亚盛医药2024-11-22